liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia
Umeå University, Sweden.
University of Uppsala Hospital, Sweden.
Karolinska University Hospital, Sweden; Karolinska Institute, Sweden.
Umeå University, Sweden.
Show others and affiliations
2016 (English)In: Leukemia, ISSN 0887-6924, E-ISSN 1476-5551, Vol. 30, no 7, 1562-1567 p.Article in journal (Refereed) PublishedText
Abstract [en]

We recently reported an increased incidence of second malignancies in chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKI). To elucidate whether this increase may be linked, not to TKI but rather to a hereditary or acquired susceptibility to develop cancer, we estimated the prevalence of malignancies, autoimmune disease (AD) and chronic inflammatory disease (CID) in CML patients prior to their CML diagnosis. Nationwide population-based registers were used to identify patients diagnosed with CML in Sweden 2002-2012 and to estimate the prevalence of other malignancies, AD and CID prior to their CML diagnosis. For each patient with CML, five matched controls were selected from the general population. Conditional logistic regression was used to calculate odds ratios (OR). Nine hundred and eighty-four CML patients were assessed, representing more than 45 000 person-years of follow-up. Compared with matched controls, the prevalence of prior malignancies and AD was elevated in CML patients: OR 1.47 (95% confidence interval (CI) 1.20-1.82) and 1.55 (95% CI 1.21-1.98), respectively. No associations were detected between CML and previous CID. An increased prevalence of other malignancies and AD prior to the diagnosis of CML suggest that a hereditary or acquired predisposition to cancer and/or autoimmunity is involved in the pathogenesis of CML.

Place, publisher, year, edition, pages
NATURE PUBLISHING GROUP , 2016. Vol. 30, no 7, 1562-1567 p.
National Category
Cancer and Oncology
URN: urn:nbn:se:liu:diva-130408DOI: 10.1038/leu.2016.59ISI: 000379504400013PubMedID: 27080811OAI: diva2:952667

Funding Agencies|Emil Andersson Research Fund; Nordic CML Study Group

Available from: 2016-08-15 Created: 2016-08-05 Last updated: 2016-08-15

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Dreimane, Arta
By organisation
Department of Clinical and Experimental MedicineFaculty of Health Sciences
In the same journal
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 19 hits
ReferencesLink to record
Permanent link

Direct link